Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | BRD2 | P25440 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4961794 | 0.91 | SMN1; SMN2 (0.38) | LMNATSHRBRD4BRD2ALDH1A1 | |
| SCHEMBL20414848 | 0.90 | LMNA (0.36) | LMNATSHRBRD4BRD2ALDH1A1 | |
| SCHEMBL11037068 | 0.84 | LMNA (0.41) | LMNATSHRBRD4BRD2ALDH1A1 | |
| SCHEMBL14693972 | 0.83 | LMNA (0.39) | LMNATSHRBRD4BRD2ALDH1A1 | |
| SCHEMBL1291207 | 0.83 | BRD4 (0.41) | LMNATSHRBRD4BRD2ALDH1A1 | |
| SCHEMBL24783971 | 0.83 | LMNA (0.39) | LMNATSHRBRD4BRD2ALDH1A1 | |
| SCHEMBL8018505 | 0.83 | TSHR (0.46) | LMNATSHRBRD4BRD2ALDH1A1 | |
| SCHEMBL891233 | 0.83 | LMNA (0.39) | LMNATSHRBRD4BRD2ALDH1A1 | |
| SCHEMBL22749300 | 0.83 | LMNA (0.39) | LMNATSHRBRD4BRD2ALDH1A1 | |
| SCHEMBL21534431 | 0.82 | PIK3CD (0.39) | LMNATSHRBRD4BRD2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 970 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023235226-A1 | SYSTEMS AND METHODS FOR INSECT CONTROL | TERRAMOR, INC. (US) | 2023-12-07 | — | — | WO | claimed |
| CN-116133639-A | Formulations and methods for treating inflammatory diseases | 维奥梅治疗公司 | 2023-05-16 | — | — | CN | claimed |
| US-20230144779-A1 | FORMULATIONS AND METHOD FOR TREATMENT OF INFLAMMATORY DISEASES | VYOME THERAPEUTICS INC. (US) | 2023-05-11 | — | — | US | claimed |
| US-20220193460-A1 | SURFACTANT-FREE FOAM FORMULATIONS | NEUBOURG SKIN CARE GMBH & CO KG (DE) | 2022-06-23 | — | — | US | claimed |
| US-11337899-B2 | Cosmetic composition | NOXELL CORPORATION (US) | 2022-05-24 | — | — | US | claimed |
| US-20210321627-A1 | NON-PESTICIDAL ATTRACT AND KILL COMPOSITION FOR CONTROL OF INSECTS | OREGON STATE UNIVERSITY (US) | 2021-10-21 | — | — | US | claimed |
| EP-3873418-A1 | COMPOSITION OF ACTIVE INGREDIENTS, FOR CARE OF HUMAN HAIR | Henkel AG & Co. KGaA (DE) | 2021-09-08 | — | — | EP | claimed |
| WO-2021124301-A1 | FORMULATIONS AND METHOD FOR TREATMENT OF INFLAMMATORY DISEASES | VYOME THERAPEUTICS INC. (US) | 2021-06-24 | — | — | WO | claimed |
| CN-112955119-A | Active ingredient composition for the care of human hair | 汉高股份有限及两合公司 | 2021-06-11 | — | — | CN | claimed |
| EP-3783115-A1 | SUGAR BEET JUICE PRODUCTION AND PROCESSING | Cooperatie Koninklijke Cosun U.A. (NL) | 2021-02-24 | — | — | EP | claimed |
| CN-101501014-A | Process for the isolation and stabilization of low molecular weight aminoglycans from waste egg shells | ROMANO DEV INC (CY) | 2009-08-05 | — | — | CN | claimed |
| EP-1999159-A2 | PROCESS FOR THE ISOLATION AND STABILIZATION OF LOW MOLECULAR WEIGHT AMINOGLYCANS FROM WASTE EGG SHELLS | Romano Development Inc. (CY) | 2008-12-10 | — | — | EP | claimed |
| US-20080051368-A1 | Process for the isolation and stabilization of low-molecular weight aminoglycans form waste egg shells | FRAMROZE BOMI P | 2008-02-28 | — | — | US | claimed |
| WO-2007110789-A2 | PROCESS FOR THE ISOLATION AND STABILIZATION OF LOW MOLECULAR WEIGHT AMINOGLYCANS FROM WASTE EGG SHELLS | ROMANO DEVELOPMENT INC. (IN) | 2007-10-04 | — | — | WO | claimed |
| US-20070224231-A1 | Anti Acne Skincare Composition and Skincare Article | RECKITT & COLMAN (OVERSEAS) LIMITED (GB) | 2007-09-27 | — | — | US | claimed |
| US-20070225484-A1 | Process for the Isolation and Stabilization of Low-Molecular Weight Aminoglycans from Waste Egg Shells | ROMANO DEVELOPMENT INC. (VG) | 2007-09-27 | — | — | US | claimed |
| US-20070148215-A1 | Therapeutically active dressings, their manufacture and use | SANGUIBIOTECH GMBH (DE) | 2007-06-28 | — | — | US | claimed |
| EP-1765269-A1 | ANTI ACNE SKINCARE COMPOSITION AND SKINCARE ARTICLE | Reckitt & Colman (Overseas) Limited (GB) | 2007-03-28 | — | — | EP | claimed |
| WO-2005110349-A1 | ANTI ACNE SKINCARE COMPOSITION AND SKINCARE ARTICLE | RECKITT & COLMAN (OVERSEAS) LIMITED (GB) | 2005-11-24 | — | — | WO | claimed |
| EP-0794246-B1 | Process for recovering valuable compounds from vinasse produced during fermentation | DSM NV (NL) | 2002-10-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080051368-A1 | Process for the isolation and stabilization of low-molecular weight aminoglycans form waste egg shells | CSGALNACT1, OSTC, FUT6 | LMNA 605/4885TSHR 4644/4885BRD4 4521/4885 |
| US-20230144779-A1 | FORMULATIONS AND METHOD FOR TREATMENT OF INFLAMMATORY DISEASES | UACA, TNF, TPMT | LMNA 2257/4885TSHR 3595/4885BRD4 2454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.